The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis. Giovannoni G, James L, Adeniran AA, Gold J, et al. Brain 2025 May 6:awaf170. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Giovannoni G, James L, Adeniran AA, Gold J, et al. The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis. Brain 2025 May 6:awaf170. doi: 10.1093.
PMID: 40327539